nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Natco Pharma Limited (NSE India Code : NATCOPHARM) BUY

Company Name :

Enter Company Name or NSE Code

NATCOPHARM Technical Levels

Resistance 2		402.25
Resistance 1		393.60
PIVOT		381.35
Support 1		372.70
Support 2		351.80

NATCOPHARM Fundamentals

Earning Growth		8.90%
Profit Margin		15.48
PE		17.18
EPS		20.16
Quarter		30-Sep-11

NATCOPHARM Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

NATCOPHARM Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

NATCOPHARM Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

NATCOPHARM Share Price on 5-10-2012

Open		384
High		389
Low		375.1
Close		378.95
Volume		23226
Change		-7.4 (-1.92%)

Series		EQ
Date of Listing		27-Dec-95
Paid Up Value		10
Face Value		10
Market Capital		0 Crores
52 Week High/Low		436.85 / 194.95

Sponsored Advertisement

Natco Pharma Limited Company Profile

Natco Pharma (NATCO) is engaged in manufacturing and marketing pharmaceutical substances and finished dosage forms. It was incorporated as a private limited company on Sept. 19, 1981; became a deemed public company on July 1, 1992 and got its current name on Feb. 18, 1993. The ISO 14001 certified company manufactures bulk actives and intermediates in branded and generic dosage forms of antibiotics, anti-malarials, cancer, oncologicals, tranquilizers, anti-depressants and other nutritional supplements, biotechnology-based drug forms and health products of natural origin. Some products include Diltiazem, Omeprazole, Lansoprazole, Isosorbides, the recent anti-cancer drug Veenat, and the generic version of Lenalidomide, which is indicated for the treatment of Myelo Dysplastic Syndrome (MDS). Late in 2007, it launched exemestane, a niche product used in the treatment of breast cancer under the brand name Xtane. The US FDA and Australian TGA approved manufacturing units are located in Nalgonda, Mehboobnagar, Hyderabad, and Dehradun with installed capacities of 1,399 million formulations and 352 Kiloliters bulk drugs and intermediates and has planned capacity expansion in FY08. The Kothur facility is dedicated exclusively for export to the US/European markets and for contract manufacturing of high premium products. Ondansetron, an anti-emetic drug, has since been accepted by the US and Canadian FDA authorities along with Citalopram Hydrobromide. Recent awards include the Patents Appreciation Award for the year 2006-2007 instituted by the Indian Drug Manufacturers Association. The company acquired 75% share in ownership and operations of the retail pharmacy stores Nicks` Drugs in New Jersey, USA. Another acquisition is SaveMart Pharmacy, a multi-utility drug store based in Pennsylvania, USA. The local marketing network covers approximately 65% of the country with clients like Sun Pharma, Ranbaxy, Novartis, Zydus Cadila and many others. The registered office is located at Natco House, Road No. 2, Banjara Hills, Hyderabad-500033.

NATCOPHARM Intraday Realtime Chart

NATCOPHARM Corporate Announcements

DATE	PURPOSE
25-Jun-12	Press Release
21-Jun-12	Press Release
29-May-12	Press Release
29-May-12	Financial Result Updates
29-May-12	Outcome of Board Meeting

NATCOPHARM Corporate Actions

DATE	PURPOSE
24-Sep-12	Annual General Meeting
22-Feb-12	Interim Dividend Rs.3/- Per Share
22-Feb-12	INT DIV-RS.3/- PER SHARE
23-Sep-11	Annual General Meeting
23-Sep-11	Annual General Meeting

NATCOPHARM Board Meetings

MEETING DATE	PURPOSE
11-Aug-12	Results/Others
28-May-12	Results/Others
09-Feb-12	Results/Dividend
09-Nov-11	Results/Others
12-Aug-11	Results/Others

NATCOPHARM Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What are the relevant rules and regulations and where can I find them?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer